shutterstock_1379742251_christopher_e_zimmer

CHRISTOPHER E ZIMMER / Shutterstock.com

26 November 2020AmericasMuireann Bolger

HHS commits to IP transparency following watchdog’s criticism

The US Department of Health and Human Services (HHS) will reveal more information regarding its licensing of IP to private companies for drug development, it has confirmed in a letter to a congressional watchdog.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

J&J, HHS sign expanded deal to find COVID-19 vaccine

14 February 2020 Johnson & Johnson unit Janssen has expanded an existing R&D agreement with the US Department of Health and Human Services (HHS) as part of efforts to speed up the development of an investigational vaccine for the novel coronavirus COVID-19.

Sanofi partners with HHS to work on COVID-19 vaccine

19 February 2020 Sanofi’s vaccine unit has united with the US Department of Health and Human Services to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.

More on this story

J&J, HHS sign expanded deal to find COVID-19 vaccine

14 February 2020 Johnson & Johnson unit Janssen has expanded an existing R&D agreement with the US Department of Health and Human Services (HHS) as part of efforts to speed up the development of an investigational vaccine for the novel coronavirus COVID-19.

Sanofi partners with HHS to work on COVID-19 vaccine

19 February 2020 Sanofi’s vaccine unit has united with the US Department of Health and Human Services to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.

More on this story

J&J, HHS sign expanded deal to find COVID-19 vaccine

14 February 2020 Johnson & Johnson unit Janssen has expanded an existing R&D agreement with the US Department of Health and Human Services (HHS) as part of efforts to speed up the development of an investigational vaccine for the novel coronavirus COVID-19.

Sanofi partners with HHS to work on COVID-19 vaccine

19 February 2020 Sanofi’s vaccine unit has united with the US Department of Health and Human Services to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent